Pulmonx (LUNG) Other financing activities (2019 - 2025)

Pulmonx (LUNG) has 5 years of Other financing activities data on file, last reported at $23000.0 in Q3 2025.

• Other financing activities for Q3 2025 came in at $23000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $76000.0 (up 43.4% YoY), and the FY2022 annual result was $53000.0, up 29.27% from the prior year.
• Other financing activities fell to $23000.0 in Q3 2025 per LUNG's latest filing, from $53000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $100000.0 in Q1 2021 and troughed at -$59000.0 in Q2 2021.
• A 3-year average of $29250.0 and a median of $38000.0 in 2022 frame the typical range for Other financing activities.
• On a YoY basis, Other financing activities climbed as much as 21.95% in 2021 and fell as far as 195.16% in 2021.
• A 3-year view of Other financing activities shows it stood at -$59000.0 in 2021, then jumped by 189.83% to $53000.0 in 2022, then tumbled by 56.6% to $23000.0 in 2025.
• Business Quant data shows LUNG's Other financing activities at $23000.0 in Q3 2025, $53000.0 in Q4 2022, and -$59000.0 in Q2 2021.